Argentina · Delayed Price · Currency is ARS AbbVie Statistics
Total Valuation
AbbVie has a market cap or net worth of ARS 552.87 trillion. The enterprise value is 641.78 trillion.
| Market Cap | 552.87T |
| Enterprise Value | 641.78T |
Important Dates
The last earnings date was Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Jan 16, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 73.80% |
| Float | 1.76B |
Valuation Ratios
The trailing PE ratio is 90.14 and the forward PE ratio is 15.22.
| PE Ratio | 90.14 |
| Forward PE | 15.22 |
| PS Ratio | 6.23 |
| PB Ratio | -146.56 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 104.63 |
| EV / Sales | 7.46 |
| EV / EBITDA | 15.51 |
| EV / EBIT | 21.51 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.34 |
| Debt / FCF | n/a |
| Interest Coverage | 8.08 |
Financial Efficiency
Return on equity (ROE) is 1,106.67% and return on invested capital (ROIC) is 22.47%.
| Return on Equity (ROE) | 1,106.67% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 22.47% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.61B |
| Profits Per Employee | 111.52M |
| Employee Count | 55,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AbbVie has paid 3.43 trillion in taxes.
| Income Tax | 3.43T |
| Effective Tax Rate | 35.83% |
Stock Price Statistics
The stock price has increased by +44.37% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +44.37% |
| 50-Day Moving Average | 33,970.40 |
| 200-Day Moving Average | 29,220.88 |
| Relative Strength Index (RSI) | 46.70 |
| Average Volume (20 Days) | 1,622 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.42 |
Income Statement
In the last 12 months, AbbVie had revenue of ARS 88.77 trillion and earned 6.13 trillion in profits. Earnings per share was 3,425.30.
| Revenue | 88.77T |
| Gross Profit | 63.60T |
| Operating Income | 30.79T |
| Pretax Income | 9.57T |
| Net Income | 6.13T |
| EBITDA | 42.70T |
| EBIT | 30.79T |
| Earnings Per Share (EPS) | 3,425.30 |
Balance Sheet
The company has 8.23 trillion in cash and 99.93 trillion in debt, with a net cash position of -91,696.55 billion.
| Cash & Cash Equivalents | 8.23T |
| Total Debt | 99.93T |
| Net Cash | -91,696.55B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -3,772.19B |
| Book Value Per Share | -2,169.69 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 71.64%, with operating and profit margins of 34.69% and 6.91%.
| Gross Margin | 71.64% |
| Operating Margin | 34.69% |
| Pretax Margin | 10.79% |
| Profit Margin | 6.91% |
| EBITDA Margin | 48.10% |
| EBIT Margin | 34.69% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 544.57, which amounts to a dividend yield of 1.65%.
| Dividend Per Share | 544.57 |
| Dividend Yield | 1.65% |
| Dividend Growth (YoY) | 43.76% |
| Years of Dividend Growth | 5 |
| Payout Ratio | n/a |
| Buyback Yield | -0.23% |
| Shareholder Yield | 1.42% |
| Earnings Yield | 1.11% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |